Cargando…
Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice
Bicyclol, a novel synthetic antihepatitis drug, has been shown to protect against liver injury via various pharmacological activities. The purpose of the current study was to further investigate the protective effect of bicyclol against carbon tetrachloride (CCl(4))-induced acute liver injury (ALI)...
Autores principales: | Zhao, Tian-Ming, Wang, Ya, Deng, You, Fan, Xiao-Fei, Cao, Xiao-Cang, Hou, Li-Jun, Mao, Li-Hong, Lin, Lin, Zhao, Wei, Wang, Bang-Mao, Jiang, Kui, Zhao, Jing-Wen, Sun, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181473/ https://www.ncbi.nlm.nih.gov/pubmed/32362825 http://dx.doi.org/10.3389/fphar.2020.00463 |
Ejemplares similares
-
Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022) -
Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats
por: Liu, Xin, et al.
Publicado: (2017) -
Bicyclol Alleviates Signs of BDL-Induced Cholestasis by Regulating Bile Acids and Autophagy-Mediated HMGB1/p62/Nrf2 Pathway
por: Zhao, Jingwen, et al.
Publicado: (2021) -
Bicyclol Attenuates Liver Inflammation Induced by Infection of Hepatitis C Virus via Repressing ROS-Mediated Activation of MAPK/NF-κB Signaling Pathway
por: Li, Hu, et al.
Publicado: (2018) -
Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation
por: Li, Hongxue, et al.
Publicado: (2021)